Aurobindo hopes to become $2 billion company in 3 years

Posted on: Wed, 25 Nov 2009 13:44:00 EST


Symbols: AUBPF
Nov 24, 2009 (The Economic Times - McClatchy-Tribune Information Services via COMTEX) --
AUBPF | Quote | Chart | News | PowerRating -- HYDERABAD, India -- Hyderabad-based pharmaceuticals company Aurobindo Pharma hopes to become a $2-billion company in the next three years, aided by improved sales from its API business and increase in profit margins , according to Ramprasad Reddy, chairman of the company.

The company, which currently has profit margins of around 18 per cent, expects to touch around 23 per cent by the next fiscal, backed by the new formulations manufacturing facility it launched in the city outskirts on Friday.

Aurobindo has invested around Rs 150 crore in setting up this manufacturing plant that will aid the manufacturing of generic pharmaceuticals products and exports globally.

The company recently joined hands with Pfizer to market its products. They are in a licensing pact to sell generic drugs in 70 emerging countries and developed markets like the US and Europe.

The company is currently doing trial batches for 25 products which would be stabilised in around three-six months. It would complete licences for 100 products by 2012. Commercial operations for the products under trial would begin by the first quarter of the next fiscal.

To see more of The Economic Times, or to subscribe to the newspaper, go to
http://economictimes.indiatimes.com Copyright (c) 2009, The Economic Times,
India Distributed by McClatchy-Tribune Information Services. For reprints, email
tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax
to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave.,
Suite 303, Glenview, IL 60025, USA.

For full details on (AUBPF) AUBPF. (AUBPF) has Short Term PowerRatings at TradingMarkets. Details on (AUBPF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.